ACLA and stakeholders ask Congress to support integrity in the practice of medicine and soften the blow to seniors by narrowing the IOAS exception, saving billions in Medicare and easing the pain of a Medicare Part B spike in premiums to certain seniors.
Presentation slides from ACLA’s 20th annual meeting, “Focus on Reimbursement, Regulation and Innovation,” are now available for viewing online.View the slides »
Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.JOIN US »
The ICD-10 transition will affect every part of your practice. Now is the time to get ready.Get Ready »
At a recent Energy and Commerce Health Subcommittee hearing, ACLA President Alan Mertz cautioned that duplicative regulation of LDTs would be harmful to innovation and patient access to diagnostic services.Read More »
A new Boston Globe editorial warns against proposed FDA guidance on laboratory developed tests.Read the Article »
Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law.